BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 2852155)

  • 1. [Effects of omeprazole and famotidine on (H+-K+) ATPase and acid secretion in rabbit gastric glands].
    Tomoi M; Itoh H; Ueda S; Ono T; Shibayama F
    Nihon Yakurigaku Zasshi; 1988 Aug; 92(2):105-11. PubMed ID: 2852155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa.
    Elander B; Fellenius E; Leth R; Olbe L; Wallmark B
    Scand J Gastroenterol; 1986 Apr; 21(3):268-72. PubMed ID: 3012768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The long-lasting effect of TU-199, a novel H+, K(+)-ATPase inhibitor, on gastric acid secretion in dogs.
    Uchiyama K; Wakatsuki D; Kakinoki B; Takeuchi Y; Araki T; Morinaka Y
    J Pharm Pharmacol; 1999 Apr; 51(4):457-64. PubMed ID: 10385219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro.
    Wallmark B; Lorentzon P; Larsson H
    Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antisecretory agents on parietal cell structure and H/K-ATPase levels in rabbit gastric mucosa in vivo.
    Scott DR; Besancon M; Sachs G; Helander H
    Dig Dis Sci; 1994 Oct; 39(10):2118-26. PubMed ID: 7924730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coupling of H(+)-K(+)-ATPase activity and glucose oxidation in gastric glands.
    Fryklund J; Gedda K; Scott D; Sachs G; Wallmark B
    Am J Physiol; 1990 May; 258(5 Pt 1):G719-27. PubMed ID: 2159239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function and structure of parietal cells after H+-K+-ATPase blockade.
    Fryklund J; Helander HF; Elander B; Wallmark B
    Am J Physiol; 1988 Mar; 254(3 Pt 1):G399-407. PubMed ID: 2831735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of a new antiulcer drug, leminoprazole, on the gastric mucosal H+,K(+)-ATPase activity in rats].
    Matsukura H; Masuda M; Uchida A; Kamishiro T
    Nihon Yakurigaku Zasshi; 1994 Aug; 104(2):91-100. PubMed ID: 7927073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. By 1023/SK&F 96022: biochemistry of a novel (H+ + K+)-ATPase inhibitor.
    Simon WA; Keeling DJ; Laing SM; Fallowfield C; Taylor AG
    Biochem Pharmacol; 1990 Jun; 39(11):1799-806. PubMed ID: 2160820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of omeprazole.
    Wallmark B
    Scand J Gastroenterol Suppl; 1986; 118():11-7. PubMed ID: 3014640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.
    Fellenius E; Berglindh T; Sachs G; Olbe L; Elander B; Sjöstrand SE; Wallmark B
    Nature; 1981 Mar; 290(5802):159-61. PubMed ID: 6259537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibitory effect of HOE 731 in isolated rabbit gastric glands.
    Herling AW; Becht M; Lang HJ; Scheunemann KH; Weidmann K; Scholl T; Rippel R
    Biochem Pharmacol; 1990 Oct; 40(8):1809-14. PubMed ID: 2173590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of an H+, K+-ATPase inhibitor, omeprazole (OPZ), on gastric acid secretion and gastric or duodenal lesion. Comparison with an H2-receptor antagonist, famotidine (FMD)].
    Haga K; Asano K; Osuga K; Maruyama Y
    Nihon Yakurigaku Zasshi; 1988 Jul; 92(1):39-47. PubMed ID: 2906028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
    Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
    J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of action of omeprazole.
    Keeling DJ; Fallowfield C; Milliner KJ; Tingley SK; Ife RJ; Underwood AH
    Biochem Pharmacol; 1985 Aug; 34(16):2967-73. PubMed ID: 2992525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of five antisecretory agents acting via gastric H+/K+-ATPase.
    Bastaki SM; Chandranath I; Garner A
    J Physiol Paris; 2000; 94(1):19-23. PubMed ID: 10761684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitory action of E3810 on H+,K(+)-ATPase and gastric acid secretion in vitro].
    Fujisaki H; Oketani K; Shibata H; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Takeguchi N
    Nihon Yakurigaku Zasshi; 1993 Dec; 102(6):389-97. PubMed ID: 8282270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific labelling of gastric H+,K+-ATPase by omeprazole.
    Fryklund J; Gedda K; Wallmark B
    Biochem Pharmacol; 1988 Jul; 37(13):2543-9. PubMed ID: 2839196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for acid-induced transformation of omeprazole into an active inhibitor of (H+ + K+)-ATPase within the parietal cell.
    Wallmark B; Brändström A; Larsson H
    Biochim Biophys Acta; 1984 Dec; 778(3):549-58. PubMed ID: 6095911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.